Cargando…
Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis
INTRODUCTION: High-dose corticosteroids remain the first-line therapy for focal and segmental glomerulosclerosis (FSGS), whereas calcineurin inhibitors (CNIs) are reserved for those patients resistant to corticosteroid therapy. METHODS: This is a retrospective cohort analysis in patients with primar...
Autores principales: | Chávez-Mendoza, Carlos Adrián, Niño-Cruz, José Antonio, Correa-Rotter, Ricardo, Uribe-Uribe, Norma Ofelia, Mejía-Vilet, Juan Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308907/ https://www.ncbi.nlm.nih.gov/pubmed/30596167 http://dx.doi.org/10.1016/j.ekir.2018.08.010 |
Ejemplares similares
-
Steroid-responsive polyradiculopathy in association with focal segmental glomerulosclerosis
por: Chapman, Andrew R., et al.
Publicado: (2013) -
Loss of Subpodocytic Space Predicts Poor Response to Tacrolimus in Steroid-Resistant Calcineurin Inhibitor-Naïve Adult-Onset Primary Focal Segmental Glomerulosclerosis
por: Agrawal, P., et al.
Publicado: (2019) -
Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children
por: Al Salloum, Abdullah A.
Publicado: (2004) -
Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature
por: Laurin, Louis-Philippe, et al.
Publicado: (2017) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007)